Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration.


Journal

Nature cardiovascular research
ISSN: 2731-0590
Titre abrégé: Nat Cardiovasc Res
Pays: England
ID NLM: 9918284280206676

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 23 04 2021
accepted: 24 05 2022
medline: 1 7 2022
pubmed: 1 7 2022
entrez: 28 8 2024
Statut: ppublish

Résumé

In mammals, the physiological activation of the glucocorticoid receptor (GR) by glucocorticoids (GCs) promotes the maturation of cardiomyocytes during late gestation, but the effect on postnatal cardiac growth and regenerative plasticity is unclear. Here we demonstrate that the GC-GR axis restrains cardiomyocyte proliferation during postnatal development. Cardiomyocyte-specific GR ablation in conditional knockout (cKO) mice delayed the postnatal cardiomyocyte cell cycle exit, hypertrophic growth and cytoarchitectural maturation. GR-cKO hearts showed increased expression of genes involved in glucose catabolism and reduced expression of genes promoting fatty acid oxidation and mitochondrial respiration. Accordingly, oxygen consumption in GR-cKO cardiomyocytes was less dependent on fatty acid oxidation, and glycolysis inhibition reverted GR-cKO effects on cardiomyocyte proliferation. GR ablation or transient pharmacological inhibition after myocardial infarction in juvenile and/or adult mice facilitated cardiomyocyte survival, cell cycle re-entry and division, leading to cardiac muscle regeneration along with reduced scar formation. Thus, GR restrains heart regeneration and may represent a therapeutic target.

Identifiants

pubmed: 39196236
doi: 10.1038/s44161-022-00090-0
pii: 10.1038/s44161-022-00090-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

617-633

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Bongiovanni, C. et al. Reawakening the intrinsic cardiac regenerative potential: molecular strategies to boost dedifferentiation and proliferation of endogenous cardiomyocytes. Front. Cardiovasc. Med. 8, 750604 (2021).
pubmed: 34692797 pmcid: 8531484 doi: 10.3389/fcvm.2021.750604
Tzahor, E. & Poss, K. D. Cardiac regeneration strategies: staying young at heart. Science 356, 1035–1039 (2017).
pubmed: 28596337 pmcid: 5614484 doi: 10.1126/science.aam5894
Sadek, H. & Olson, E. N. Toward the goal of human heart regeneration. Cell Stem Cell 26, 7–16 (2020).
pubmed: 31901252 pmcid: 7257208 doi: 10.1016/j.stem.2019.12.004
Eschenhagen, T. et al. Cardiomyocyte regeneration: a consensus statement. Circulation 136, 680–686 (2017).
pubmed: 28684531 pmcid: 5557671 doi: 10.1161/CIRCULATIONAHA.117.029343
van Berlo, J. H. & Molkentin, J. D. An emerging consensus on cardiac regeneration. Nat. Med. 20, 1386–1393 (2014).
pubmed: 25473919 pmcid: 4418535 doi: 10.1038/nm.3764
Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078–1080 (2011).
pubmed: 21350179 pmcid: 3099478 doi: 10.1126/science.1200708
Drenckhahn, J.-D. et al. Compensatory growth of healthy cardiac cells in the presence of diseased cells restores tissue homeostasis during heart development. Dev. Cell 15, 521–533 (2008).
pubmed: 18854137 doi: 10.1016/j.devcel.2008.09.005
Sampaio-Pinto, V. et al. Neonatal apex resection triggers cardiomyocyte proliferation, neovascularization and functional recovery despite local fibrosis. Stem Cell Rep. 10, 860–874 (2018).
doi: 10.1016/j.stemcr.2018.01.042
Haubner, B. J. et al. Complete cardiac regeneration in a mouse model of myocardial infarction. Aging 4, 966–977 (2012).
pubmed: 23425860 pmcid: 3615162 doi: 10.18632/aging.100526
Ye, L. et al. Early regenerative capacity in the porcine heart. Circulation 138, 2798–2808 (2018).
pubmed: 30030417 doi: 10.1161/CIRCULATIONAHA.117.031542
Zhu, W. et al. Regenerative potential of neonatal porcine hearts. Circulation 138, 2809–2816 (2018).
pubmed: 30030418 pmcid: 6301098 doi: 10.1161/CIRCULATIONAHA.118.034886
Li, Y. et al. Genetic tracing identifies early segregation of the cardiomyocyte and nonmyocyte lineages. Circ. Res. 125, 343–355 (2019).
pubmed: 31185811 doi: 10.1161/CIRCRESAHA.119.315280
Jopling, C. et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464, 606–609 (2010).
pubmed: 20336145 pmcid: 2846535 doi: 10.1038/nature08899
Kikuchi, K. et al. Primary contribution to zebrafish heart regeneration by gata4
pubmed: 20336144 pmcid: 3040215 doi: 10.1038/nature08804
Soonpaa, M. H., Kim, K. K., Pajak, L., Franklin, M. & Field, L. J. Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. 271, H2183–H2189 (1996).
pubmed: 8945939
Li, F., Wang, X., Capasso, J. M. & Gerdes, A. M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 28, 1737–1746 (1996).
pubmed: 8877783 doi: 10.1006/jmcc.1996.0163
Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98–102 (2009).
pubmed: 19342590 pmcid: 2991140 doi: 10.1126/science.1164680
Senyo, S. E. et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433–436 (2013).
pubmed: 23222518 doi: 10.1038/nature11682
Uygur, A. & Lee, R. T. Mechanisms of cardiac regeneration. Dev. Cell 36, 362–374 (2016).
pubmed: 26906733 pmcid: 4768311 doi: 10.1016/j.devcel.2016.01.018
Heallen, T. R., Kadow, Z. A., Kim, J. H., Wang, J. & Martin, J. F. Stimulating cardiogenesis as a treatment for heart failure. Circ. Res. 124, 1647–1657 (2019).
pubmed: 31120819 pmcid: 6534162 doi: 10.1161/CIRCRESAHA.118.313573
Hashimoto, H., Olson, E. N. & Bassel-Duby, R. Therapeutic approaches for cardiac regeneration and repair. Nat. Rev. Cardiol. 15, 585–600 (2018).
pubmed: 29872165 pmcid: 6241533 doi: 10.1038/s41569-018-0036-6
Cahill, T. J., Choudhury, R. P. & Riley, P. R. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nat. Rev. Drug Discov. 16, 699–717 (2017).
pubmed: 28729726 doi: 10.1038/nrd.2017.106
Galdos, F. X. et al. Cardiac regeneration: lessons from development. Circ. Res. 120, 941–959 (2017).
pubmed: 28302741 pmcid: 5358810 doi: 10.1161/CIRCRESAHA.116.309040
Oakley, R. H. & Cidlowski, J. A. Glucocorticoid signaling in the heart: a cardiomyocyte perspective. J. Steroid Biochem. Mol. Biol. 153, 27–34 (2015).
pubmed: 25804222 pmcid: 4568128 doi: 10.1016/j.jsbmb.2015.03.009
Richardson, R. V., Batchen, E. J., Denvir, M. A., Gray, G. A. & Chapman, K. E. Cardiac GR and MR: from development to pathology. Trends Endocrinol. Metab. 27, 35–43 (2016).
pubmed: 26586027 doi: 10.1016/j.tem.2015.10.001
Rog-Zielinska, E. A., Richardson, R. V., Denvir, M. A. & Chapman, K. E. Glucocorticoids and foetal heart maturation; implications for prematurity and foetal programming. J. Mol. Endocrinol. 52, R125–R135 (2014).
pubmed: 24299741 doi: 10.1530/JME-13-0204
Giraud, G. D., Louey, S., Jonker, S., Schultz, J. & Thornburg, K. L. Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus. Endocrinology 147, 3643–3649 (2006).
pubmed: 16690807 doi: 10.1210/en.2006-0061
Feng, X., Reini, S. A., Richards, E., Wood, C. E. & Keller-Wood, M. Cortisol stimulates proliferation and apoptosis in the late gestation fetal heart: differential effects of mineralocorticoid and glucocorticoid receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R343–R350 (2013).
pubmed: 23785077 pmcid: 3833392 doi: 10.1152/ajpregu.00112.2013
de Vries, W. B. et al. Suppression of physiological cardiomyocyte proliferation in the rat pup after neonatal glucocorticosteroid treatment. Basic Res. Cardiol. 101, 36–42 (2006).
pubmed: 16283594 doi: 10.1007/s00395-005-0557-0
Gay, M. S., Li, Y., Xiong, F., Lin, T. & Zhang, L. Dexamethasone treatment of newborn rats decreases cardiomyocyte endowment in the developing heart through epigenetic modifications. PLoS ONE 10, e0125033 (2015).
pubmed: 25923220 pmcid: 4414482 doi: 10.1371/journal.pone.0125033
Cutie, S., Payumo, A. Y., Lunn, D. & Huang, G. N. In vitro and in vivo roles of glucocorticoid and vitamin D receptors in the control of neonatal cardiomyocyte proliferative potential. J. Mol. Cell. Cardiol. 142, 126–134 (2020).
pubmed: 32289320 pmcid: 7395852 doi: 10.1016/j.yjmcc.2020.04.013
Tao, Z. et al. Dexamethasone inhibits regeneration and causes ventricular aneurysm in the neonatal porcine heart after myocardial infarction. J. Mol. Cell. Cardiol. 144, 15–23 (2020).
pubmed: 32387242 doi: 10.1016/j.yjmcc.2020.04.033
Hattori, F. et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods 7, 61–66 (2010).
pubmed: 19946277 doi: 10.1038/nmeth.1403
Genangeli, M. et al. Development and application of a UHPLC–MS/MS method for the simultaneous determination of 17 steroidal hormones in equine serum. J. Mass Spectrom. 52, 22–29 (2017).
pubmed: 27790795 doi: 10.1002/jms.3896
Morgan, R. A. et al. Dysregulation of cortisol metabolism in equine pituitary pars intermedia dysfunction. Endocrinology 159, 3791–3800 (2018).
pubmed: 30289445 pmcid: 6202856 doi: 10.1210/en.2018-00726
Perogamvros, I., Ray, D. W. & Trainer, P. J. Regulation of cortisol bioavailability—effects on hormone measurement and action. Nat. Rev. Endocrinol. 8, 717–727 (2012).
pubmed: 22890008 doi: 10.1038/nrendo.2012.134
Savu, L., Nunez, E. & Jayle, M. F. Corticosterone binding by mouse sera during foetal and post-natal development. Acta Endocrinol. 84, 177–190 (1977).
doi: 10.1530/acta.0.0840177
Oakley, R. H. et al. Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease. Proc. Natl Acad. Sci. USA 110, 17035–17040 (2013).
pubmed: 24082121 pmcid: 3801058 doi: 10.1073/pnas.1302546110
Ali, H., Braga, L. & Giacca, M. Cardiac regeneration and remodelling of the cardiomyocyte cytoarchitecture. FEBS J. 287, 417–438 (2020).
pubmed: 31743572 doi: 10.1111/febs.15146
Piquereau, J. & Ventura-Clapier, R. Maturation of cardiac energy metabolism during perinatal development. Front. Physiol. 9, 959 (2018).
pubmed: 30072919 pmcid: 6060230 doi: 10.3389/fphys.2018.00959
Bae, J., Paltzer, W. G. & Mahmoud, A. I. The role of metabolism in heart failure and regeneration. Front. Cardiovasc. Med. 8, 702920 (2021).
pubmed: 34336958 pmcid: 8322239 doi: 10.3389/fcvm.2021.702920
Sim, C. B. et al. Sex-specific control of human heart maturation by the progesterone receptor. Circulation 143, 1614–1628 (2021).
pubmed: 33682422 pmcid: 8055196 doi: 10.1161/CIRCULATIONAHA.120.051921
Kubin, T. et al. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell 9, 420–432 (2011).
pubmed: 22056139 doi: 10.1016/j.stem.2011.08.013
D’Uva, G. et al. ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nat. Cell Biol. 17, 627–638 (2015).
pubmed: 25848746 doi: 10.1038/ncb3149
Puente, B. N. et al. The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 157, 565–579 (2014).
pubmed: 24766806 pmcid: 4104514 doi: 10.1016/j.cell.2014.03.032
Honkoop, H. et al. Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart. eLife 8, e50163 (2019).
pubmed: 31868166 pmcid: 7000220 doi: 10.7554/eLife.50163
Cardoso, A. C. et al. Mitochondrial substrate utilization regulates cardiomyocyte cell-cycle progression. Nat. Metab. 2, 167–178 (2020).
pubmed: 32617517 pmcid: 7331943 doi: 10.1038/s42255-020-0169-x
Mills, R. J. et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc. Natl Acad. Sci. USA 114, E8372–E8381 (2017).
pubmed: 28916735 pmcid: 5635889 doi: 10.1073/pnas.1707316114
Cao, T. et al. Fatty acid oxidation promotes cardiomyocyte proliferation rate but does not change cardiomyocyte number in infant mice. Front. Cell Dev. Biol. 7, 42 (2019).
pubmed: 30968022 pmcid: 6440456 doi: 10.3389/fcell.2019.00042
Severinova, E. et al. Glucocorticoid receptor-binding and transcriptome signature in cardiomyocytes. J. Am. Heart Assoc. 8, e011484 (2019).
Talman, V. et al. Molecular atlas of postnatal mouse heart development. J. Am. Heart Assoc. 7, e010378 (2018).
pubmed: 30371266 pmcid: 6474944 doi: 10.1161/JAHA.118.010378
Parikh, S. S. et al. Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes. Circ. Res. 121, 1323–1330 (2017).
pubmed: 28974554 pmcid: 5722667 doi: 10.1161/CIRCRESAHA.117.311920
Karbassi, E. et al. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat. Rev. Cardiol. 17, 341–359 (2020).
pubmed: 32015528 pmcid: 7239749 doi: 10.1038/s41569-019-0331-x
Hirose, K. et al. Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. Science 364, 184–188 (2019).
pubmed: 30846611 pmcid: 6541389 doi: 10.1126/science.aar2038
Su, Q.-Q., Huang, X.-L., Qin, J. & Liu, Q.-S. Assessment of effects of mifepristone administration to lactating mice on the development and fertility of their progeny. J. Obstet. Gynaecol. Res. 41, 575–581 (2015).
pubmed: 25331362 doi: 10.1111/jog.12589

Auteurs

Nicola Pianca (N)

Scientific and Technological Pole, IRCCS MultiMedica, Milan, Italy.

Francesca Sacchi (F)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Centre for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy.
National Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems (INBB), Bologna, Italy.

Kfir Baruch Umansky (KB)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Maila Chirivì (M)

Institute of Biochemistry and Cell Biology (IBBC), National Research Council of Italy (CNR), Monterotondo Scalo, Rome, Italy.
National Institute of Molecular Genetics (INGM) 'Romeo ed Enrica Invernizzi', Milan, Italy.

Luisa Iommarini (L)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Silvia Da Pra (S)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Centre for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy.
National Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems (INBB), Bologna, Italy.

Valentina Papa (V)

Department of Biomedical and Neuromotors Sciences, Anatomic Pathology at S. Orsola Hospital, University of Bologna, Bologna, Italy.

Chiara Bongiovanni (C)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Centre for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy.
National Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems (INBB), Bologna, Italy.

Carmen Miano (C)

Centre for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy.
National Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems (INBB), Bologna, Italy.

Francesca Pontis (F)

Scientific and Technological Pole, IRCCS MultiMedica, Milan, Italy.

Luca Braga (L)

British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, King's College London, London, UK.

Riccardo Tassinari (R)

Eldor Lab c/o National Research Council of Italy (CNR), Bologna, Italy.

Elvira Pantano (E)

Scientific and Technological Pole, IRCCS MultiMedica, Milan, Italy.

Rahul Shastry Patnala (RS)

Scientific and Technological Pole, IRCCS MultiMedica, Milan, Italy.

Martina Mazzeschi (M)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Giovanna Cenacchi (G)

Department of Biomedical and Neuromotors Sciences, Anatomic Pathology at S. Orsola Hospital, University of Bologna, Bologna, Italy.

Anna Maria Porcelli (AM)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Mattia Lauriola (M)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Carlo Ventura (C)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
National Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems (INBB), Bologna, Italy.

Mauro Giacca (M)

British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, King's College London, London, UK.

Roberto Rizzi (R)

National Institute of Molecular Genetics (INGM) 'Romeo ed Enrica Invernizzi', Milan, Italy.
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.

Eldad Tzahor (E)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Gabriele D'Uva (G)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy. gabrielematteo.duva2@unibo.it.
Centre for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy. gabrielematteo.duva2@unibo.it.
National Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems (INBB), Bologna, Italy. gabrielematteo.duva2@unibo.it.

Classifications MeSH